peline, Takeda is positioned to bring life-transforming medicines that improve patient lives and deliver long-term shareholder value.”

FINANCIAL HIGHLIGHTS for FY2025 Q3 YTD Ended December 31, 2025






(Billion yen, except percentages and per share amounts)







Item



FY2025 Q3 YTD



FY2024 Q3 YTD



vs. PRIOR YEAR

(Actual % change)







Revenue



3,411.2



3,528.2



-3.3%







Operating Profit



422.4



417.5



+1.2%







Net Profit



216.1



211.1



+2.4%




=*=*=*=*=*=
当前为第3/18页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页